Literature DB >> 21484165

Modulation of endothelial cell proliferation and capillary network formation by the ox-LDL component: 1-palmitoyl-2-archidonoyl-sn-glycero-3-phosphocholine (ox-PAPC).

B Kiec-Wilk1, A Polus, U Razny, U Cialowicz, A Dembinska-Kiec.   

Abstract

Atherosclerotic plaque formation is often associated with pathological angiogenesis. Modified phospholipids, including oxidized lipoproteins such as LDL, are found to induce adhesion of the monocytes to the endothelial cells and to stimulate their chemotaxis. Effects of oxidized 1-palmitoyl-2-archidonoyl-sn-glycero-3-phosphocholine (ox-PAPC) mimic actions of minimally modified LDL in vivo. Interleukin-8 (IL-8) and interleukin-15 (IL-15) are known to induce both inflammation and angiogenesis. The goal of our study was to analyze a potential synergism between ox-PAPC and IL-15 in the in vitro model of angiogenesis carried out in the human endothelial cells (HUVECs). Increasing IL-15 concentrations led to formation of the tube-like structures in the matrigel 3D-model of angiogenesis (P < 0.05), in contrast to ox-PAPC that inhibited this process. HUVECs incubation with ox-PAPC led to reduced IL-15 gene basal expression (P = 0.033) along with parallel increase, however statistically insignificant, of basal gene expression of IL-8 (P = 0.086). Our findings point to the ox-PAPC opposite effects on the IL-8- and IL-15-mediated angiogenic responses that contribute to pathological angiogenesis induced by ox-LDL.

Entities:  

Year:  2011        PMID: 21484165      PMCID: PMC3197846          DOI: 10.1007/s12263-010-0208-4

Source DB:  PubMed          Journal:  Genes Nutr        ISSN: 1555-8932            Impact factor:   5.523


  11 in total

1.  Oxidized phospholipids stimulate tissue factor expression in human endothelial cells via activation of ERK/EGR-1 and Ca(++)/NFAT.

Authors:  Valery N Bochkov; Diana Mechtcheriakova; Marcus Lucerna; Joakim Huber; Roland Malli; Wolfgang F Graier; Erhard Hofer; Bernd R Binder; Norbert Leitinger
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

2.  Interleukin-15 promotes angiogenesis in vivo.

Authors:  A L Angiolillo; H Kanegane; C Sgadari; G H Reaman; G Tosato
Journal:  Biochem Biophys Res Commun       Date:  1997-04-07       Impact factor: 3.575

3.  Interleukin-15 expression in atherosclerotic plaques: an alternative pathway for T-cell activation in atherosclerosis?

Authors:  M A Houtkamp; A C van Der Wal; O J de Boer; C M van Der Loos; P A de Boer; A F Moorman; A E Becker
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-07       Impact factor: 8.311

4.  Proangiogenic activity of beta-carotene is coupled with the activation of endothelial cell chemotaxis.

Authors:  A Dembinska-Kiec; A Polus; B Kiec-Wilk; J Grzybowska; M Mikolajczyk; J Hartwich; U Razny; K Szumilas; A Banas; M Bodzioch; J Stachura; G Dyduch; P Laidler; J Zagajewski; T Langman; G Schmitz
Journal:  Biochim Biophys Acta       Date:  2004-12-28

Review 5.  Autophagy in atherosclerosis: a cell survival and death phenomenon with therapeutic potential.

Authors:  Wim Martinet; Guido R Y De Meyer
Journal:  Circ Res       Date:  2009-02-13       Impact factor: 17.367

Review 6.  Therapeutic potential of interleukin-15: a myokine involved in muscle wasting and adiposity.

Authors:  Josep M Argilés; Francisco J López-Soriano; Sílvia Busquets
Journal:  Drug Discov Today       Date:  2008-12-16       Impact factor: 7.851

7.  Oxidized phospholipids increase interleukin 8 (IL-8) synthesis by activation of the c-src/signal transducers and activators of transcription (STAT)3 pathway.

Authors:  Michael Yeh; Nima M Gharavi; Jenny Choi; Xavier Hsieh; Erin Reed; Kevin P Mouillesseaux; Amy L Cole; Srinivasa T Reddy; Judith A Berliner
Journal:  J Biol Chem       Date:  2004-05-13       Impact factor: 5.157

Review 8.  Biomarkers in cardiovascular diabetology: interleukins and matrixins.

Authors:  Enrique Z Fisman; Yehuda Adler; Alexander Tenenbaum
Journal:  Adv Cardiol       Date:  2008

Review 9.  New approach to cancer therapy: heparin binding-epidermal growth factor-like growth factor as a novel targeting molecule.

Authors:  Shingo Miyamoto; Hiroshi Yagi; Fusanori Yotsumoto; Shinji Horiuchi; Toshiyuki Yoshizato; Tatsuhiko Kawarabayashi; Masahide Kuroki; Eisuke Mekada
Journal:  Anticancer Res       Date:  2007 Nov-Dec       Impact factor: 2.480

10.  The antibody-mediated targeted delivery of interleukin-15 and GM-CSF to the tumor neovasculature inhibits tumor growth and metastasis.

Authors:  Manuela Kaspar; Eveline Trachsel; Dario Neri
Journal:  Cancer Res       Date:  2007-05-15       Impact factor: 12.701

View more
  1 in total

1.  4-Hydroxynonenal Contributes to Angiogenesis through a Redox-Dependent Sphingolipid Pathway: Prevention by Hydralazine Derivatives.

Authors:  Caroline Camaré; Corinne Vanucci-Bacqué; Nathalie Augé; Mélanie Pucelle; Corinne Bernis; Audrey Swiader; Michel Baltas; Florence Bedos-Belval; Robert Salvayre; Anne Nègre-Salvayre
Journal:  Oxid Med Cell Longev       Date:  2017-04-05       Impact factor: 6.543

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.